APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Steroids Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ophthalmic Steroids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchOphthalmic Steroids Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Steroids Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Ophthalmic Steroids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Steroids Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Steroids Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ophthalmic Steroids Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Steroids Drug include Alimera Sciences, Allergan, Bausch and Lomb, Genentech, Novartis AG, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International, Bayer AG and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Steroids Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Steroids Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Steroids Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Steroids Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Steroids Drug Segment by Company

Alimera Sciences

Allergan

Bausch and Lomb

Genentech

Novartis AG

Regeneron Pharmaceuticals

Valeant Pharmaceuticals International

Bayer AG

GlaxoSmithKline

Pfizer

Ophthalmic Steroids Drug Segment by Type

Allergic Conjunctivitis

Keratitis

Uveitis

Diabetic Macular Edema

Others

Ophthalmic Steroids Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Research Institute

Hospital Pharmacies

Others

Ophthalmic Steroids Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Steroids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Steroids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Steroids Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Steroids Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ophthalmic Steroids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ophthalmic Steroids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Steroids Drug Industry Trends Table 2. Ophthalmic Steroids Drug Industry Drivers Table 3. Ophthalmic Steroids Drug Industry Opportunities and Challenges Table 4. Ophthalmic Steroids Drug Industry Restraints Table 5. Global Ophthalmic Steroids Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Steroids Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ophthalmic Steroids Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Ophthalmic Steroids Drug Sales Market Share by Manufacturers Table 9. Global Ophthalmic Steroids Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Ophthalmic Steroids Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ophthalmic Steroids Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ophthalmic Steroids Drug Manufacturers, Product Type & Application Table 13. Global Ophthalmic Steroids Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Steroids Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Allergic Conjunctivitis Table 17. Major Manufacturers of Keratitis Table 18. Major Manufacturers of Uveitis Table 19. Major Manufacturers of Diabetic Macular Edema Table 20. Major Manufacturers of Others Table 21. Global Ophthalmic Steroids Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 23. Global Ophthalmic Steroids Drug Sales by Type (2027-2032) & (K Units) Table 24. Global Ophthalmic Steroids Drug Sales Market Share by Type (2021-2026) Table 25. Global Ophthalmic Steroids Drug Sales Market Share by Type (2027-2032) Table 26. Global Ophthalmic Steroids Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Ophthalmic Steroids Drug Revenue by Type (2021-2026) & (K Units) Table 28. Global Ophthalmic Steroids Drug Revenue by Type (2027-2032) & (K Units) Table 29. Global Ophthalmic Steroids Drug Revenue Market Share by Type (2021-2026) Table 30. Global Ophthalmic Steroids Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Major Manufacturers of Research Institute Table 34. Major Manufacturers of Hospital Pharmacies Table 35. Major Manufacturers of Others Table 36. Global Ophthalmic Steroids Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 38. Global Ophthalmic Steroids Drug Sales by Application (2027-2032) & (K Units) Table 39. Global Ophthalmic Steroids Drug Sales Market Share by Application (2021-2026) Table 40. Global Ophthalmic Steroids Drug Sales Market Share by Application (2027-2032) Table 41. Global Ophthalmic Steroids Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ophthalmic Steroids Drug Revenue by Application (2021-2026) & (K Units) Table 43. Global Ophthalmic Steroids Drug Revenue by Application (2027-2032) & (K Units) Table 44. Global Ophthalmic Steroids Drug Revenue Market Share by Application (2021-2026) Table 45. Global Ophthalmic Steroids Drug Revenue Market Share by Application (2027-2032) Table 46. Global Ophthalmic Steroids Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Ophthalmic Steroids Drug Sales by Region (2021-2026) & (K Units) Table 48. Global Ophthalmic Steroids Drug Sales Market Share by Region (2021-2026) Table 49. Global Ophthalmic Steroids Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Ophthalmic Steroids Drug Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 53. North America Ophthalmic Steroids Drug Sales by Country (2027-2032) & (K Units) Table 54. Europe Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 56. Europe Ophthalmic Steroids Drug Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Ophthalmic Steroids Drug Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2027-2032) & (K Units) Table 63. Global Ophthalmic Steroids Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Ophthalmic Steroids Drug Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Ophthalmic Steroids Drug Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Ophthalmic Steroids Drug Revenue Market Share by Region (2021-2026) Table 67. Global Ophthalmic Steroids Drug Revenue Market Share by Region (2027-2032) Table 68. Alimera Sciences Company Information Table 69. Alimera Sciences Business Overview Table 70. Alimera Sciences Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alimera Sciences Ophthalmic Steroids Drug Product Portfolio Table 72. Alimera Sciences Recent Development Table 73. Allergan Company Information Table 74. Allergan Business Overview Table 75. Allergan Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Allergan Ophthalmic Steroids Drug Product Portfolio Table 77. Allergan Recent Development Table 78. Bausch and Lomb Company Information Table 79. Bausch and Lomb Business Overview Table 80. Bausch and Lomb Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio Table 82. Bausch and Lomb Recent Development Table 83. Genentech Company Information Table 84. Genentech Business Overview Table 85. Genentech Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Genentech Ophthalmic Steroids Drug Product Portfolio Table 87. Genentech Recent Development Table 88. Novartis AG Company Information Table 89. Novartis AG Business Overview Table 90. Novartis AG Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novartis AG Ophthalmic Steroids Drug Product Portfolio Table 92. Novartis AG Recent Development Table 93. Regeneron Pharmaceuticals Company Information Table 94. Regeneron Pharmaceuticals Business Overview Table 95. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio Table 97. Regeneron Pharmaceuticals Recent Development Table 98. Valeant Pharmaceuticals International Company Information Table 99. Valeant Pharmaceuticals International Business Overview Table 100. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio Table 102. Valeant Pharmaceuticals International Recent Development Table 103. Bayer AG Company Information Table 104. Bayer AG Business Overview Table 105. Bayer AG Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bayer AG Ophthalmic Steroids Drug Product Portfolio Table 107. Bayer AG Recent Development Table 108. GlaxoSmithKline Company Information Table 109. GlaxoSmithKline Business Overview Table 110. GlaxoSmithKline Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio Table 112. GlaxoSmithKline Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Ophthalmic Steroids Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Pfizer Ophthalmic Steroids Drug Product Portfolio Table 117. Pfizer Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Ophthalmic Steroids Drug Distributors List Table 121. Ophthalmic Steroids Drug Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Ophthalmic Steroids Drug Product Image Figure 2. Global Ophthalmic Steroids Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Steroids Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Steroids Drug Sales (2021-2032) & (K Units) Figure 5. Global Ophthalmic Steroids Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ophthalmic Steroids Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Allergic Conjunctivitis Image Figure 9. Keratitis Image Figure 10. Uveitis Image Figure 11. Diabetic Macular Edema Image Figure 12. Others Image Figure 13. Global Ophthalmic Steroids Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Ophthalmic Steroids Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ophthalmic Steroids Drug Sales Market Share by Type (2021-2032) Figure 16. Global Ophthalmic Steroids Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Ophthalmic Steroids Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmic Steroids Drug Revenue Market Share by Type (2021-2032) Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Research Institute Image Figure 22. Hospital Pharmacies Image Figure 23. Others Image Figure 24. Global Ophthalmic Steroids Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Ophthalmic Steroids Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Ophthalmic Steroids Drug Sales Market Share by Application (2021-2032) Figure 27. Global Ophthalmic Steroids Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Ophthalmic Steroids Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Ophthalmic Steroids Drug Revenue Market Share by Application (2021-2032) Figure 30. North America Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Ophthalmic Steroids Drug Sales Market Share by Country (2021-2032) Figure 32. U.S. Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Ophthalmic Steroids Drug Sales Market Share by Country (2021-2032) Figure 37. Germany Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Ophthalmic Steroids Drug Sales Market Share by Country (2021-2032) Figure 44. China Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Ophthalmic Steroids Drug Sales Market Share by Country (2021-2032) Figure 52. Brazil Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Ophthalmic Steroids Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Ophthalmic Steroids Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Ophthalmic Steroids Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Ophthalmic Steroids Drug Revenue (2021-2032) & (US$ Million) Figure 63. North America Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Ophthalmic Steroids Drug Revenue (2021-2032) & (US$ Million) Figure 65. Europe Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Ophthalmic Steroids Drug Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Ophthalmic Steroids Drug Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Ophthalmic Steroids Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Ophthalmic Steroids Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Allergic Conjunctivitis
  • Keratitis
  • Uveitis
  • Diabetic Macular Edema
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Research Institute
  • Hospital Pharmacies
  • Others
Companies covered
  • Alimera Sciences
  • Allergan
  • Bausch and Lomb
  • Genentech
  • Novartis AG
  • Regeneron Pharmaceuticals
  • Valeant Pharmaceuticals International
  • Bayer AG
  • GlaxoSmithKline
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmic Steroids Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmic Steroids Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ophthalmic Steroids Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ophthalmic Steroids Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ophthalmic Steroids Drug Market Dynamics
  1. 2.1 Ophthalmic Steroids Drug Industry Trends
  2. 2.2 Ophthalmic Steroids Drug Industry Drivers
  3. 2.3 Ophthalmic Steroids Drug Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Steroids Drug Industry Restraints
3 Ophthalmic Steroids Drug Market by Manufacturers
  1. 3.1 Global Ophthalmic Steroids Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ophthalmic Steroids Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ophthalmic Steroids Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ophthalmic Steroids Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Steroids Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ophthalmic Steroids Drug Manufacturers, Product Type & Application
  7. 3.7 Global Ophthalmic Steroids Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Steroids Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Steroids Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Steroids Drug Tier 1, Tier 2, and Tier 3
4 Ophthalmic Steroids Drug Market by Type
  1. 4.1 Ophthalmic Steroids Drug Type Introduction
  2. 4.1.1 Allergic Conjunctivitis
  3. 4.1.2 Keratitis
  4. 4.1.3 Uveitis
  5. 4.1.4 Diabetic Macular Edema
  6. 4.1.5 Others
  7. 4.2 Global Ophthalmic Steroids Drug Sales by Type
  8. 4.2.1 Global Ophthalmic Steroids Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Ophthalmic Steroids Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Ophthalmic Steroids Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Ophthalmic Steroids Drug Revenue by Type
  12. 4.3.1 Global Ophthalmic Steroids Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Ophthalmic Steroids Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Ophthalmic Steroids Drug Revenue Market Share by Type (2021-2032)
5 Ophthalmic Steroids Drug Market by Application
  1. 5.1 Ophthalmic Steroids Drug Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Research Institute
  5. 5.1.4 Hospital Pharmacies
  6. 5.1.5 Others
  7. 5.2 Global Ophthalmic Steroids Drug Sales by Application
  8. 5.2.1 Global Ophthalmic Steroids Drug Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Ophthalmic Steroids Drug Sales by Application (2021-2032)
  10. 5.2.3 Global Ophthalmic Steroids Drug Sales Market Share by Application (2021-2032)
  11. 5.3 Global Ophthalmic Steroids Drug Revenue by Application
  12. 5.3.1 Global Ophthalmic Steroids Drug Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Ophthalmic Steroids Drug Revenue by Application (2021-2032)
  14. 5.3.3 Global Ophthalmic Steroids Drug Revenue Market Share by Application (2021-2032)
6 Global Ophthalmic Steroids Drug Sales by Region
  1. 6.1 Global Ophthalmic Steroids Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Steroids Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Steroids Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Ophthalmic Steroids Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ophthalmic Steroids Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ophthalmic Steroids Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ophthalmic Steroids Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ophthalmic Steroids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ophthalmic Steroids Drug Revenue by Region
  1. 7.1 Global Ophthalmic Steroids Drug Revenue by Region
  2. 7.1.1 Global Ophthalmic Steroids Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ophthalmic Steroids Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Ophthalmic Steroids Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Ophthalmic Steroids Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ophthalmic Steroids Drug Revenue (2021-2032)
  8. 7.2.2 North America Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ophthalmic Steroids Drug Revenue (2021-2032)
  11. 7.3.2 Europe Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ophthalmic Steroids Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ophthalmic Steroids Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ophthalmic Steroids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alimera Sciences
  2. 8.1.1 Alimera Sciences Company Information
  3. 8.1.2 Alimera Sciences Business Overview
  4. 8.1.3 Alimera Sciences Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alimera Sciences Ophthalmic Steroids Drug Product Portfolio
  6. 8.1.5 Alimera Sciences Recent Developments
  7. 8.2 Allergan
  8. 8.2.1 Allergan Company Information
  9. 8.2.2 Allergan Business Overview
  10. 8.2.3 Allergan Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergan Ophthalmic Steroids Drug Product Portfolio
  12. 8.2.5 Allergan Recent Developments
  13. 8.3 Bausch and Lomb
  14. 8.3.1 Bausch and Lomb Company Information
  15. 8.3.2 Bausch and Lomb Business Overview
  16. 8.3.3 Bausch and Lomb Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio
  18. 8.3.5 Bausch and Lomb Recent Developments
  19. 8.4 Genentech
  20. 8.4.1 Genentech Company Information
  21. 8.4.2 Genentech Business Overview
  22. 8.4.3 Genentech Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genentech Ophthalmic Steroids Drug Product Portfolio
  24. 8.4.5 Genentech Recent Developments
  25. 8.5 Novartis AG
  26. 8.5.1 Novartis AG Company Information
  27. 8.5.2 Novartis AG Business Overview
  28. 8.5.3 Novartis AG Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis AG Ophthalmic Steroids Drug Product Portfolio
  30. 8.5.5 Novartis AG Recent Developments
  31. 8.6 Regeneron Pharmaceuticals
  32. 8.6.1 Regeneron Pharmaceuticals Company Information
  33. 8.6.2 Regeneron Pharmaceuticals Business Overview
  34. 8.6.3 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio
  36. 8.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 8.7 Valeant Pharmaceuticals International
  38. 8.7.1 Valeant Pharmaceuticals International Company Information
  39. 8.7.2 Valeant Pharmaceuticals International Business Overview
  40. 8.7.3 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio
  42. 8.7.5 Valeant Pharmaceuticals International Recent Developments
  43. 8.8 Bayer AG
  44. 8.8.1 Bayer AG Company Information
  45. 8.8.2 Bayer AG Business Overview
  46. 8.8.3 Bayer AG Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer AG Ophthalmic Steroids Drug Product Portfolio
  48. 8.8.5 Bayer AG Recent Developments
  49. 8.9 GlaxoSmithKline
  50. 8.9.1 GlaxoSmithKline Company Information
  51. 8.9.2 GlaxoSmithKline Business Overview
  52. 8.9.3 GlaxoSmithKline Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio
  54. 8.9.5 GlaxoSmithKline Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Ophthalmic Steroids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Ophthalmic Steroids Drug Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Steroids Drug Value Chain Analysis
  2. 9.1.1 Ophthalmic Steroids Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Steroids Drug Production Mode & Process
  6. 9.2 Ophthalmic Steroids Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Steroids Drug Distributors
  9. 9.2.3 Ophthalmic Steroids Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst